Study of ISIS 301012 (Mipomersen) in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy

NCT00281008 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia, Familial

Interventions

DRUG: ISIS 301012 or Placebo
DRUG: ISIS 301012 or Placebo
DRUG: ISIS 301012 or Placebo
DRUG: ISIS 301012 or Placebo

Sponsor

Kastle Therapeutics, LLC

Collaborators

[object Object]